Boston Scientific Corporation (LON:0HOY)
97.39
+0.94 (0.97%)
At close: Oct 9, 2025
Boston Scientific Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2005 - 2019 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2005 - 2019 |
Cash & Equivalents | 534 | 414 | 865 | 928 | 1,925 | 1,734 | Upgrade |
Cash & Short-Term Investments | 534 | 414 | 865 | 928 | 1,925 | 1,734 | Upgrade |
Cash Growth | -81.67% | -52.14% | -6.79% | -51.79% | 11.02% | 699.08% | Upgrade |
Accounts Receivable | 2,815 | 2,558 | 2,228 | 1,970 | 1,778 | 1,531 | Upgrade |
Inventory | 2,861 | 2,810 | 2,484 | 1,867 | 1,610 | 1,351 | Upgrade |
Other Current Assets | 911 | 1,138 | 936 | 995 | 1,004 | 2,078 | Upgrade |
Total Current Assets | 7,121 | 6,920 | 6,514 | 5,760 | 6,317 | 6,694 | Upgrade |
Net Property, Plant & Equipment | 3,461 | 3,294 | 2,859 | 2,446 | 2,252 | 2,084 | Upgrade |
Other Intangible Assets | 7,260 | 6,684 | 6,003 | 5,902 | 6,121 | 5,917 | Upgrade |
Goodwill | 18,076 | 17,089 | 14,387 | 12,920 | 11,988 | 9,951 | Upgrade |
Other Long-Term Assets | 5,642 | 5,409 | 5,372 | 5,442 | 5,552 | 6,131 | Upgrade |
Total Assets | 41,559 | 39,395 | 35,136 | 32,469 | 32,229 | 30,777 | Upgrade |
Accounts Payable | 962 | 960 | 942 | 862 | 794 | 513 | Upgrade |
Accrued Expenses | 2,797 | 2,773 | 2,646 | 2,160 | 2,436 | 2,197 | Upgrade |
Short-Term Debt | 480 | 1,778 | 531 | 20 | 261 | 13 | Upgrade |
Other Current Liabilities | 952 | 887 | 814 | 761 | 783 | 958 | Upgrade |
Total Current Liabilities | 5,190 | 6,399 | 4,933 | 3,803 | 4,274 | 3,681 | Upgrade |
Long-Term Debt | 11,107 | 8,968 | 8,571 | 8,915 | 8,804 | 9,130 | Upgrade |
Other Long-Term Liabilities | 2,609 | 2,025 | 2,101 | 2,179 | 2,530 | 2,639 | Upgrade |
Total Long-Term Liabilities | 13,716 | 10,993 | 10,672 | 11,094 | 11,334 | 11,769 | Upgrade |
Total Liabilities | 18,906 | 17,392 | 15,605 | 14,897 | 15,608 | 15,450 | Upgrade |
Common Stock | 17 | 17 | 17 | 17 | 17 | 17 | Upgrade |
Treasury Stock | -2,251 | -2,251 | -2,251 | -2,251 | -2,251 | -2,251 | Upgrade |
Additional Paid-in Capital | 21,230 | 21,056 | 20,647 | 20,289 | 19,986 | 19,732 | Upgrade |
Accumulated Other Comprehensive Income | -722 | 275 | 49 | 269 | 263 | 207 | Upgrade |
Retained Earnings | 4,144 | 2,673 | 819 | -750 | -1,392 | -2,378 | Upgrade |
Total Common Shareholders' Equity | 22,418 | 21,770 | 19,282 | 17,573 | 16,622 | 15,326 | Upgrade |
Minority Interest | 235 | 233 | 248 | - | - | - | Upgrade |
Shareholders' Equity | 22,653 | 22,003 | 19,530 | 17,573 | 16,622 | 15,326 | Upgrade |
Total Liabilities & Equity | 41,559 | 39,395 | 35,136 | 32,469 | 32,229 | 30,777 | Upgrade |
Total Debt | 11,587 | 10,746 | 9,102 | 8,935 | 9,065 | 9,143 | Upgrade |
Net Cash (Debt) | -11,053 | -10,332 | -8,237 | -8,007 | -7,140 | -7,409 | Upgrade |
Net Cash Per Share | -7.41 | -6.95 | -5.63 | -5.56 | -4.98 | -5.23 | Upgrade |
Book Value | 22,418 | 21,770 | 19,282 | 17,573 | 16,622 | 15,326 | Upgrade |
Book Value Per Share | 15.04 | 14.65 | 13.18 | 12.21 | 11.59 | 10.82 | Upgrade |
Tangible Book Value | -2,918 | -2,003 | -1,108 | -1,249 | -1,487 | -542 | Upgrade |
Tangible Book Value Per Share | -1.96 | -1.35 | -0.76 | -0.87 | -1.04 | -0.38 | Upgrade |
Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.